Quant Healthcare Fund - Growth Option - Regular Plan
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 11-07-2023
AUM:
₹ 358.11 Cr
Expense Ratio
2.42%
Benchmark
BSE Healthcare TRI
ISIN
INF966L01CG3
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
1000
Fund Manager
Mr. Sandeep Tandon
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Quant Healthcare Fund - Growth Option - Regular Plan | -2.69 | - | - |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
14.7313
Last change
0 (0.0333%)
Fund Size (AUM)
₹ 358.11 Cr
Performance
16.76% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Manager
Mr. Sandeep Tandon
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| CIPLA LIMITED EQ NEW FV RS.2/- | 10.01 |
| SMS PHARMACEUTICALS LIMITED EQ NEW FV Re.1/- | 9.58 |
| SEQUENT SCIENTIFIC LIMITED EQ NEW FV RS. 2/- | 8.5 |
| Zydus Wellness Limited | 8.05 |
| ASTER DM HEALTHCARE LIMITED EQ | 7.6 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 7.09 |
| PFIZER LIMITED EQ | 6.6 |
| GLENMARK LIFE SCIENCES LIMITED EQ NEW FV Rs.2/- | 6.23 |
| ANTHEM BIOSCIENCES PRIVATE LIMITED EQ NEW FV Rs. 2/- | 6.0 |
| ADANI ENTERPRISES LIMITED EQ NEW FV RE.1/- | 5.87 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 69.64 |
| Fast Moving Consumer Goods | 8.05 |
| Metals & Mining | 6.29 |
| Automobile and Auto Components | 4.09 |